Background Image
Table of Contents Table of Contents
Previous Page  20 / 56 Next Page
Information
Show Menu
Previous Page 20 / 56 Next Page
Page Background

18

VOLUME 13 NUMBER 1 • JULY 2016

RESEARCH ARTICLE

SA JOURNAL OF DIABETES & VASCULAR DISEASE

Statistical analysis

Using SPSS 17.0, data were analysed and expressed as mean ±

standard deviation. Comparisons across the groups were done using

analysis of variance, and associations were verified by Spearman’s

correlation. Agreement between methods was assessed using

Bland and Altman plots of the difference against the means of the

two methods.

Results

Participants were 12 males and 12 females, aged 54 ± 15 years.

Their mean body mass index was 28.9 ± 5.8 kg/m

2

, mean systolic

and diastolic blood pressures were 128 ± 18 and 77 ± 8 mmHg,

respectively, and mean haemoglobin was 13.4 ± 1.8 g/dl. The

duration of diabetes in all patients was 10 ± 6 years with a pre-

inclusion HbA

1c

value of 7.8 ± 2.3%.

Overall, there was no statistically significant difference between

mean HbA

1c

measurements across the sites (Table 1). The correlation

between measurements varied from

r

= 0.89,

p

< 0.001 between

the 650-m/1 600-m altitudes,

r

= 0.92, p < 0.001 between the

13-m/650-m altitudes, to

r

= 0.96,

p

< 0.001 between 13-m/1

600-m altitudes. The coefficient of variation (CV) was 3.4% for the

650-m/13-m duplicates, 5.1% for 1 600-m/13-m duplicates and

3.2% for 1 600-m/650-m duplicates.

The mean differences expressed as estimates (95% CI) in

percentages between measurements at two different sites

were –0.04 (–1.05−0.97%), +0.14 (0.95−1.24%) and +0.13

(–0.45−0.70%), respectively, between the 650-m/13-m (Fig. 1A),

1 600-m/650-m (Fig. 1B), and 1 600-m/13-m altitudes (Fig. 1C).

The HbA

1c

differences were > 0.5% (8 mmol/mol) in 3/24 (12%)

between the 1 600-m/13-m measurements, 4/24 (17%) between

the 650-m/13-m measurements and in 6/24 (25%) between the

1 600-m/650-m measurements. In only one case associated with

more than one percentage difference across sites was a patient

with one of the readings at 4.2% (22 mmol/mol) in one site, which

normally would have prompted a second check. We did not find any

differences in the percentage variation of HbA

1c

levels at the low (

n

= 12), medium (

n

= 6) and high (

n

= 6) values for the different study

sites, namely 650-m/13-m (

p

= 0.453), 1 600-m/650-m (

p

= 0.111)

and 1 600-m/13-m altitudes (

p

= 0.344).

Table 1.

Comparison of mean HbA

1c

levels by group across the sites

Point-of-care In2it analyser

Study group Douala Yaounde Bamenda

p

-value

(13 m)

(650 m)

(1 600 m)

Healthy controls

5.0 ± 0.6 5.4 ± 0.3 5.6 ± 0.5 0.15

Patients with diabetes

HbA

1c

< 6.5% 5.9 ± 0.6 5.7 ± 0.6 5.9 ± 0.4 0.29

(< 49 mmol/mol)

HbA

1c

6.5–8.0% 8.1 ± 3.0 7.9 ± 3.1 8.0 ± 3.0 0.66

(49–64 mmol/mol)

HbA

1c

> 8.0% 8.4 ± 1.8 8.5 ± 1.7 9.0 ± 2.2 0.84

(> 64 mmol/mol)

All study participants 6.8 ± 2.2 6.9 ± 2.2 7.1 ± 2.3 0.31

Discussion

This study indicates that the POC analyser showed no significant

differences across Cameroonian sites located at altitudes varying

from 13 to 1 600 m (≤ 0.5% in 75% of comparisons). Although

measurements were not repeated in each site to reflect clinical

practice, our results suggest a test reliability of the In2it POC

instrument below 1 600 m.

Interestingly, previous studies in which the device calibration was

performed with HPLC, had suggested satisfactory external validity.

7

This was however not investigated in our study and therefore

represents a major limitation with the sample size.

However, considering our findings and the cut-off value of 3.5%

of CV for optimal performance between laboratories (between

study sites in our case), one could say that although no significant

difference was observed between HbA

1c

levels at the three altitudes,

the POC apparatus had a relatively high variability between 13 and

1 600 m.

8

As expected, this variability was higher in low and normal

HbA

1c

levels (not shown).

In this regard, the use of the POC HbA

1c

analyser could be more

indicated for the monitoring of patients with a view to comparing

Figure 1.

Plots of the differences against averages of POC HbA

1c

levels at 13-m and 650-m altitudes (A), 1 600-m and 650-m altitudes (B), and a1 600-m and 13-m

altitudes (C), with mean difference (bias) and 95% agreement limits.